Wuhan LL Science and Technology Development Co. patents P2X4 receptor antagonists June 25, 2021 No Comments
Topline phase II data for nezulcitinib in patients hospitalized with ALI due to COVID-19 June 21, 2021 No Comments
MediciNova initiates sheep study to develop MN-166 as treatment for chlorine gas-induced lung injury June 8, 2021 No Comments
Completion of target enrollment in part A of phase I/II study of MRx-4DP0004 in asthma June 7, 2021 No Comments
Extracellular nicotinamide phosphoribosyltransferase suggested as a viable ARDS therapeutic target May 31, 2021 No Comments
Liminal stops plans to advance fezagepras into trials for IPF and hypertriglyceridemia May 31, 2021 No Comments
Cynata begins MEND trial of Cymerus mesenchymal stem cells in respiratory failure May 25, 2021 No Comments
RSS